Pharm
Bromocriptine
search
Bromocriptine
, Bromocriptine QR, Parlodel, Cycloset
See Also
Dopamine Agonist in Hyperprolactinemia
Cabergoline
Dopamine Agonist
Hyperprolactinemia
Galactorrhea
Indications
Acromegaly
Hyperprolactinemia
Adjunctive management of pituitary tumors
Parkinsonism
(listed for historical reasons)
Replaced by non-ergot derived
Dopamine Agonist
s
Dopamine Agonist
s are used for late
Parkinsonism
following tolerance to
Levodopa
Neuroleptic Malignant Syndrome
(not FDA approved)
Contraindications
Raynaud's Syndrome
Mechanism
Ergot derived
Dopamine
receptor
Agonist
(esp. D2 receptors)
Dosing
Hyperprolactinemia
Preparations: Bromocriptine (Parlodel)
Indications
Larger safety database than
Cabergoline
(preferred in women trying to conceive)
Oral Dosing
Start: 1.25 to 2.5 mg orally at bedtime
Titrate: Increase by 2.5 mg/dose every 3-7 days up to 15 mg daily
Maximum: 40 mg/day
Alternative: Vaginal Dosing (not FDA approved)
Dose: 2.5 to 7.5 mg intravaginally (if gastrointestinal symptoms prevent oral dosing)
Dosing
Acromegaly
Target dose: 20-30 mg/day (divided twice daily if total dose >20 mg)
Maximum: 100 mg/day
Dosing
Neuroleptic Malignant Syndrome
Take 2.5 to 5 mg orally 2 to 6 times daily
Dosing
Diabetes Mellitus
2
Preparations: Bromocriptine QR or Cycloset
Indications (historical)
Adjunctive with
Metformin
(and other
Oral Hypoglycemic
agents)
Dosing
Start 0.8 mg each am
May increase up to weekly by 0.8 mg/day, to a maximum of 4.8 mg daily
Efficacy
May lower
Hemoglobin A1C
0.7 to 1.4%
References
Joe Weidner, MD (2018) email communication, received 11/10/2018
Gardner (2013) Endocr Pract 19(1):100-6 +PMID:23337160 [PubMed]
Chamarthi (2017) Postgrad Med 129(4):446-455 +PMID:28374645 [PubMed]
Adverse Effects
Take with food to reduce adverse effects (
Nausea
,
Dizziness
)
Safety
Pregnancy Category B
Avoid in
Lactation
Cardiovascular Events (CVA, MI,
Arrhythmia
s)
Nausea
Hallucination
s
Confusion
CNS Activation
Resources
Bromocriptine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93a0696b-b261-4262-9e06-f3180b419f8f
References
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 46-7
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Huang (2012) Am Fam Physician 85(11): 1073-80 [PubMed]
Type your search phrase here